Thermo Fisher Scientific Inc. (TMO)

Market Cap	174.55B +10.3%
Revenue (ttm)	45.20B +5.4%
Net Income	6.85B +5.1%
EPS	18.19 +6.7%
Shares Out	371.62M
PE Ratio	25.82
Forward PE	18.47
Dividend	$1.88 (0.40%)
Ex-Dividend Date	Mar 13, 2026

Volume	2,684,516
Open	469.15
Previous Close	466.70
Day's Range	464.66 - 475.00
52-Week Range	385.46 - 643.99
Beta	0.97
Analysts	Strong Buy
Price Target	636.00 (+35.4%)
Earnings Date	Apr 23, 2026

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: NYSE
• Ticker Symbol: TMO
• Website: https://www.thermofisher.com

Financial Performance

In 2025, Thermo Fisher's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.

Analyst Summary

According to 18 analysts, the average rating for TMO stock is "Strong Buy." The 12-month stock price target is $636.0, which is an increase of 35.40% from the latest price.

Price Target

$636.0

(35.40% upside)

Analyst Consensus: Strong Buy